Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Cash from Investing Activities (2016 - 2025)

Medifast (MED) has disclosed Cash from Investing Activities for 16 consecutive years, with -$5.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 74.53% year-over-year to -$5.0 million, compared with a TTM value of -$7.9 million through Dec 2025, up 70.11%, and an annual FY2025 reading of -$7.9 million, up 70.11% over the prior year.
  • Cash from Investing Activities was -$5.0 million for Q4 2025 at Medifast, up from -$14.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $13.4 million in Q2 2025 and bottomed at -$46.5 million in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$6.8 million, with a median of -$2.7 million recorded in 2024.
  • The sharpest move saw Cash from Investing Activities tumbled 2527.66% in 2023, then surged 627.53% in 2025.
  • Year by year, Cash from Investing Activities stood at -$11.6 million in 2021, then rose by 22.02% to -$9.1 million in 2022, then fell by 18.39% to -$10.7 million in 2023, then plummeted by 81.07% to -$19.4 million in 2024, then soared by 74.53% to -$5.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for MED at -$5.0 million in Q4 2025, -$14.3 million in Q3 2025, and $13.4 million in Q2 2025.